AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

MedLife S.A.

Board/Management Information Oct 21, 2024

2292_iss_2024-10-21_cdca01a3-bb7c-438b-8211-028e157a8a90.pdf

Board/Management Information

Open in Viewer

Opens in native device viewer

To: BUCHAREST STOCK EXCHANGE FINANCIAL SUPERVISORY AUTHORITY

CURRENT REPORT

Current report drafted according to the stipulations of ASF Regulation no. 5/2018 on issuers of financial instruments and market operations, Law no. 24/2017 on issuers of financial instruments and market operations, and the provisions of Article 99 of the Bucharest Stock Exchange Code, Title II, Issuers and Financial Instruments

Report Date: 21 October 2024 Name of the issuing company: MED LIFE S.A. ("MedLife" or "the Company") Registered Office: Bucharest, Calea Grivitei, no. 365, district 1, Romania Telephone / Fax number: 0374 180 470 Unique Registration Code at the National Office of Trade Registry: 8422035 Order number on the Trade Registry: J40/3709/1996 Subscribed and paid-in share capital: 132,870,492 RON Total number of shares: 531,481,968 (out of which 417,042 shares without voting rights and 531,064,926 shares with voting rights) Regulated market on which the issued securities are traded: Bucharest Stock Exchange, Premium Category

Significant events to report:

The Decision of the Board of Directors of MED LIFE S.A.

MED LIFE S.A. informs shareholders and investors that, by decision of the Company's Board of Directors, it was unanimously decided by all administrators, with a vote of 'for':

Considering the expiration of the mandates of the members of the Executive Committee of the Company on October 21, 2024, the mandates of the following members will be extended, starting from October 21, 2024, until October 20, 2028:

  • Mr. Mihail Marcu as Chief Executive Officer and Member of the Executive Committee;
  • Mr. Nicolae Marcu as Director of Health and Operations and Member of the Executive Committee;
  • Mr. Dorin Preda as Deputy Chief Executive Officer and Member of the Executive Committee;
  • Ms. Oana-Alina Irinoiu as Chief Financial Officer and Member of the Executive Committee.

The new Executive Committee of the Company is reduced from 10 to 5 members, with 4 members appointed as stated above and one position remaining vacant.

Mihail Marcu Chief Executive Officer

______________

Talk to a Data Expert

Have a question? We'll get back to you promptly.